Related Experiment Video
Updated: May 31, 2026

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
Published on: March 2, 2014
A dual-pronged host-directed therapeutic targeting cyclophilin A and pathogenic interferon response abrogates
Wenzhe Yu1,2, Hongmin Cao2, Zhifang Deng2
1Department of Obstetrics and Gynecology, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, Guangdong-Hong Kong-Macao Greater Bay Area Higher Education Joint Laboratory of Maternal-Fetal Medicine, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Abstract:
Pathogenic viruses threaten fetal development by achieving vertical transmission and instigating placental immunopathology, while the pathobiological mechanisms and effective therapeutics remain critical gaps. Here, we reveal cyclophilin A (CypA) as a crucial host factor necessary for Zika virus (ZIKV) replication in human placental trophoblasts, acting independently of its canonical functions. ZIKV infection recruits CypA into the viral replication organelle and reconfigures its interactome, thereby subverting host RNA decay machinery and stress granule-mediated antiviral surveillance. Both genetic ablation of CypA and its pharmacological inhibition with clinically approved drug ciclosporin A (CsA) restrict ZIKV transplacental transmission and corresponding placental and fetal pathologies. Beyond its anti-ZIKV potency, CsA concurrently counteracts pathological type I interferon signaling by targeting the JAK1-STAT1/2 pathway, broadly ameliorating pregnancy-specific interferonopathies driven by viral infection or endogenous double-stranded RNA stress. Our findings elucidate CypA-governed ZIKV pathogenesis and license CsA as a promising dual-action therapeutic to counteract congenital viral infections.
Insights
Cyclophilin A (CypA) is essential for Zika virus (ZIKV) replication in the placenta. Inhibiting CypA with ciclosporin A (CsA) blocks ZIKV transmission and reduces fetal harm.
Area of Science:
- Virology and Immunology
- Maternal-Fetal Medicine
- Drug Discovery
Background:
- Pathogenic viruses can transmit vertically, causing placental immunopathology and threatening fetal development.
- Mechanisms of viral pathogenesis and effective therapeutics for congenital infections remain significant research gaps.
Purpose of the Study:
- To identify host factors crucial for Zika virus (ZIKV) replication in human placental cells.
- To investigate the therapeutic potential of targeting these host factors against ZIKV and related pregnancy complications.
Main Methods:
- Investigated the role of cyclophilin A (CypA) in ZIKV replication within human placental trophoblasts.
- Utilized genetic ablation of CypA and pharmacological inhibition with ciclosporin A (CsA).
- Assessed ZIKV transplacental transmission, placental pathology, and fetal outcomes.
- Analyzed the impact of CsA on type I interferon signaling pathways (JAK1-STAT1/2).
Main Results:
- Cyclophilin A (CypA) is essential for ZIKV replication in placental trophoblasts, independent of its known functions.
- ZIKV infection recruits CypA, disrupting host RNA decay and antiviral surveillance.
- Genetic deletion or CsA inhibition of CypA significantly restricted ZIKV transplacental transmission and associated pathologies.
- CsA also ameliorated type I interferonopathies by inhibiting the JAK1-STAT1/2 pathway.
Conclusions:
- Cyclophilin A (CypA) is a critical host factor in ZIKV pathogenesis and placental infection.
- Ciclosporin A (CsA) demonstrates dual efficacy by inhibiting ZIKV replication and counteracting pathological interferon responses.
- CsA represents a promising therapeutic candidate for managing congenital viral infections and pregnancy-specific interferonopathies.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Inhibitors of Virion Maturation and Assembly
Antiviral Nucleoside Inhibitors
Inhibitors Of Virion Release
Viruses with RNA Genomes

